The crucial distinction occurs at transcript processing. In XX embryos, the early dosage-sensitive signal permits Sex-lethal transcripts to be spliced into a form that produces functional Sxl protein. This converts an initial difference associated with X-chromosome dosage into a molecular state capable of directing later sex-specific regulation during development.
Once functional Sxl protein is produced, self-maintenance becomes central. It promotes continued female-specific splicing of its own transcripts, so the regulatory state does not depend only on the initiating signal. This feedback provides developmental stability: an early decision is reinforced over time and can continue to influence downstream gene expression in XX embryos.
Sex-lethal influences different downstream processes rather than one single output. It regulates alternative splicing of transformer, while also controlling translation of msl-2. These targets connect the upstream regulatory state to distinct molecular consequences, allowing the same gene-control system to coordinate sexual development with the pathway that balances X-chromosome gene expression.
In XY embryos, the feedback that maintains female-specific Sxl splicing is not established. As a result, the embryo follows male-specific developmental and dosage-compensation pathways rather than the XX regulatory state. This contrast demonstrates that the outcome depends on whether the early dosage-sensitive signal successfully initiates and maintains the Sxl program.
It brings several regulatory questions into one biological system. Researchers can connect an early dosage-sensitive decision with transcript splicing, self-reinforcing feedback, downstream target regulation, sexual development, and X-chromosome expression balance. Because these steps are linked, the gene provides a framework for examining how post-transcriptional control shapes developmental outcomes.
A focused analysis can trace three linked features: whether Sex-lethal transcripts undergo the female-specific splicing pattern, whether functional Sxl protein is maintained, and how transformer splicing and msl-2 translation respond. Comparing these features between XX and XY embryos helps relate the initiating dosage signal to developmental and dosage-compensation outcomes.